Start Date
January 14, 2019
Primary Completion Date
August 31, 2020
Study Completion Date
August 31, 2020
Cyclosporine A
"Initial treatment: Oral cyclosporine A (CsA) treatment (4-5 mg/kg/day) for 3 weeks.~Responders shift to oral low-dose CsA treatment (2-2.5 mg/kg/day) until onset of a second flare or until Week 16 (Day 113).~In case of a second AD flare, the subjects shift back to oral high-dose CsA treatment (4-5 mg/kg/day) for 3 weeks."
Investigational site, Rotterdam
Lead Sponsor
LEO Pharma
INDUSTRY